Literature DB >> 22232556

Protein kinase C (PKC)ζ-mediated Gαq stimulation of ERK5 protein pathway in cardiomyocytes and cardiac fibroblasts.

Carlota García-Hoz1, Guzmán Sánchez-Fernández, Ramón García-Escudero, María Fernández-Velasco, Julia Palacios-García, Marisol Ruiz-Meana, Maria Teresa Díaz-Meco, Michael Leitges, Jorge Moscat, David García-Dorado, Lisardo Boscá, Federico Mayor, Catalina Ribas.   

Abstract

Gq-coupled G protein-coupled receptors (GPCRs) mediate the actions of a variety of messengers that are key regulators of cardiovascular function. Enhanced Gα(q)-mediated signaling plays an important role in cardiac hypertrophy and in the transition to heart failure. We have recently described that Gα(q) acts as an adaptor protein that facilitates PKCζ-mediated activation of ERK5 in epithelial cells. Because the ERK5 cascade is known to be involved in cardiac hypertrophy, we have investigated the potential relevance of this pathway in cardiovascular Gq-dependent signaling using both cultured cardiac cell types and chronic administration of angiotensin II in mice. We find that PKCζ is required for the activation of the ERK5 pathway by Gq-coupled GPCR in neonatal and adult murine cardiomyocyte cultures and in cardiac fibroblasts. Stimulation of ERK5 by angiotensin II is blocked upon pharmacological inhibition or siRNA-mediated silencing of PKCζ in primary cultures of cardiac cells and in neonatal cardiomyocytes isolated from PKCζ-deficient mice. Moreover, upon chronic challenge with angiotensin II, these mice fail to promote the changes in the ERK5 pathway, in gene expression patterns, and in hypertrophic markers observed in wild-type animals. Taken together, our results show that PKCζ is essential for Gq-dependent ERK5 activation in cardiomyocytes and cardiac fibroblasts and indicate a key cardiac physiological role for the Gα(q)/PKCζ/ERK5 signaling axis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232556      PMCID: PMC3293562          DOI: 10.1074/jbc.M111.282210

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

Review 1.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

2.  Multisite phosphorylation of Erk5 in mitosis.

Authors:  Elena Díaz-Rodríguez; Atanasio Pandiella
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

3.  Activity assays for extracellular signal-regulated kinase 5.

Authors:  Kazuhiro Nakamura; Gary L Johnson
Journal:  Methods Mol Biol       Date:  2010

4.  G alpha(q) acts as an adaptor protein in protein kinase C zeta (PKCzeta)-mediated ERK5 activation by G protein-coupled receptors (GPCR).

Authors:  Carlota García-Hoz; Guzmán Sánchez-Fernández; Maria Teresa Díaz-Meco; Jorge Moscat; Federico Mayor; Catalina Ribas
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

5.  Fine tuning NF-κB: new openings for PKC-ζ.

Authors:  Jorge Moscat; Maria T Diaz-Meco
Journal:  Nat Immunol       Date:  2011-01       Impact factor: 25.606

6.  Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4).

Authors:  Nils Ohnesorge; Dorothee Viemann; Nicole Schmidt; Tobias Czymai; Désirée Spiering; Mirco Schmolke; Stephan Ludwig; Johannes Roth; Matthias Goebeler; Marc Schmidt
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

7.  Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes.

Authors:  J B Decock; J Gillespie-Brown; P J Parker; P H Sugden; S J Fuller
Journal:  FEBS Lett       Date:  1994-12-19       Impact factor: 4.124

8.  A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer.

Authors:  Qin Wang; Andrew J Symes; Corrina A Kane; Alex Freeman; Joseph Nariculam; Philippa Munson; Christopher Thrasivoulou; John R W Masters; Aamir Ahmed
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

9.  Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.

Authors:  Tomomi E Kimura; Jiawei Jin; Min Zi; Sukhpal Prehar; Wei Liu; Delvac Oceandy; Jun-ichi Abe; Ludwig Neyses; Arthur H Weston; Elizabeth J Cartwright; Xin Wang
Journal:  Circ Res       Date:  2010-01-14       Impact factor: 17.367

10.  Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.

Authors:  Yulin Liao; Masanori Asakura; Seiji Takashima; Akiko Ogai; Yoshihiro Asano; Yasunori Shintani; Tetsuo Minamino; Hiroshi Asanuma; Shoji Sanada; Jiyoong Kim; Soichiro Kitamura; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

View more
  15 in total

1.  Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis.

Authors:  Raelene J Pickering; Christos Tikellis; Carlos J Rosado; Despina Tsorotes; Alexandra Dimitropoulos; Monique Smith; Olivier Huet; Ruth M Seeber; Rekhati Abhayawardana; Elizabeth Km Johnstone; Jonathan Golledge; Yutang Wang; Karin A Jandeleit-Dahm; Mark E Cooper; Kevin Dg Pfleger; Merlin C Thomas
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

Review 2.  Targeting G protein-coupled receptor signalling by blocking G proteins.

Authors:  Adrian P Campbell; Alan V Smrcka
Journal:  Nat Rev Drug Discov       Date:  2018-09-28       Impact factor: 84.694

3.  Sirtuin 1 represses PKC-ζ activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy.

Authors:  Jingyan Li; Junying Huang; Jing Lu; Zhen Guo; Zhuoming Li; Hui Gao; Panxia Wang; Wenwei Luo; Sidong Cai; Yuehuai Hu; Kaiteng Guo; Luping Wang; Zhenzhen Li; Minghui Wang; Xiaolei Zhang; Peiqing Liu
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

Review 4.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

5.  Activation of transient receptor potential canonical 3 (TRPC3)-mediated Ca2+ entry by A1 adenosine receptor in cardiomyocytes disturbs atrioventricular conduction.

Authors:  Jessica Sabourin; Fabrice Antigny; Elodie Robin; Maud Frieden; Eric Raddatz
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

6.  PRMT7 ablation in cardiomyocytes causes cardiac hypertrophy and fibrosis through β-catenin dysregulation.

Authors:  Byeong-Yun Ahn; Myong-Ho Jeong; Jung-Hoon Pyun; Hyeon-Ju Jeong; Tuan Anh Vuong; Ju-Hyeon Bae; Subin An; Su Woo Kim; Yong Kee Kim; Dongryeol Ryu; Hyun-Ji Kim; Hana Cho; Gyu-Un Bae; Jong-Sun Kang
Journal:  Cell Mol Life Sci       Date:  2022-01-28       Impact factor: 9.261

7.  Effects of Wenyangzhenshuai Granule on ERK1/2 and ERK5 activity in the myocardial tissue in a rabbit model of adriamycin-induced chronic heart failure.

Authors:  Xinyu Chen; Huzhi Cai; Qingyang Chen; Haibo Xie; Yuemei Liu; Qing Lu; Yanping Tang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

8.  Protein Kinase C ζ Interacts with a Novel Binding Region of Gαq to Act as a Functional Effector.

Authors:  Guzmán Sánchez-Fernández; Sofía Cabezudo; Álvaro Caballero; Carlota García-Hoz; Gregory G Tall; Javier Klett; Stephen W Michnick; Federico Mayor; Catalina Ribas
Journal:  J Biol Chem       Date:  2016-02-17       Impact factor: 5.157

9.  ERK5 activation by Gq-coupled muscarinic receptors is independent of receptor internalization and β-arrestin recruitment.

Authors:  Guzmán Sánchez-Fernández; Sofía Cabezudo; Carlota García-Hoz; Andrew B Tobin; Federico Mayor; Catalina Ribas
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

10.  PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.

Authors:  Laszlo Deres; Eva Bartha; Anita Palfi; Krisztian Eros; Adam Riba; Janos Lantos; Tamas Kalai; Kalman Hideg; Balazs Sumegi; Ferenc Gallyas; Kalman Toth; Robert Halmosi
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.